Free Trial
NASDAQ:LIPO

Lipella Pharmaceuticals (LIPO) Stock Price, News & Analysis

Lipella Pharmaceuticals logo
$0.59 -0.01 (-1.22%)
As of 08/22/2025 02:47 PM Eastern

About Lipella Pharmaceuticals Stock (NASDAQ:LIPO)

Key Stats

Today's Range
$0.59
$0.60
50-Day Range
$0.57
$2.87
52-Week Range
$0.55
$7.31
Volume
1,098 shs
Average Volume
879,551 shs
Market Capitalization
$2.73 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive LIPO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lipella Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

LIPO Stock News Headlines

Get This Stock Now
This company is the lifeblood of AI data centers, yet almost no one has caught up with the story. Their hardware is so essential that the data center industry uses enough of it to stretch around the world 8 times – in a single building! So, if you own Nvidia stock now, you might be well-served to sell those shares and check out this under-the-radar play instead. Or if you missed the boat on Nvidia, this is a rare second chance to target tremendous profit potential as AI data centers spring up in every corner of the world.tc pixel
See More Headlines

LIPO Stock Analysis - Frequently Asked Questions

Lipella Pharmaceuticals' stock was trading at $3.05 at the start of the year. Since then, LIPO shares have decreased by 80.6% and is now trading at $0.5902.

Lipella Pharmaceuticals Inc. (NASDAQ:LIPO) released its earnings results on Wednesday, May, 14th. The company reported ($0.64) EPS for the quarter. The firm had revenue of $0.13 million for the quarter. Lipella Pharmaceuticals had a negative trailing twelve-month return on equity of 224.08% and a negative net margin of 988.83%.

Lipella Pharmaceuticals's stock reverse split on Friday, November 8th 2024.A 1-8 reverse split was announced. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, November 7th 2024. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split.

Lipella Pharmaceuticals (LIPO) raised $7 million in an IPO on Tuesday, December 20th 2022. The company issued 1,217,391 shares at a price of $5.75 per share.

Shares of LIPO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Lipella Pharmaceuticals investors own include Sangamo Therapeutics (SGMO), MSP Recovery (LIFW), NVIDIA (NVDA), Heatwurx (PCSA), Energy Transfer (ET), Labor Smart (LTNC) and NIO (NIO).

Company Calendar

Last Earnings
5/14/2025
Today
8/23/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:LIPO
CIK
1347242
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($3.43)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$5.02 million
Net Margins
-988.83%
Pretax Margin
-988.63%
Return on Equity
-224.08%
Return on Assets
-172.88%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.21
Quick Ratio
6.21

Sales & Book Value

Annual Sales
$536.36 thousand
Price / Sales
4.92
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.59 per share
Price / Book
0.37

Miscellaneous

Outstanding Shares
4,467,000
Free Float
3,033,000
Market Cap
$2.64 million
Optionable
Not Optionable
Beta
-0.10

Social Links

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:LIPO) was last updated on 8/24/2025 by MarketBeat.com Staff
From Our Partners